Inoue J - Search Results

1

Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.

Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S, Inazawa J. Sonoda I, et al. Among authors: inoue j. Cancer Res. 2004 Jun 1;64(11):3741-7. doi: 10.1158/0008-5472.CAN-04-0172. Cancer Res. 2004. PMID: 15172977

2

MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.

Janssen JW, Imoto I, Inoue J, Shimada Y, Ueda M, Imamura M, Bartram CR, Inazawa J. Janssen JW, et al. Among authors: inoue j. J Hum Genet. 2002;47(9):460-4. doi: 10.1007/s100380200065. J Hum Genet. 2002. PMID: 12202983

3

PPM1D is a potential target for 17q gain in neuroblastoma.

Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T, Inazawa J. Saito-Ohara F, et al. Among authors: inoue j. Cancer Res. 2003 Apr 15;63(8):1876-83. Cancer Res. 2003. PMID: 12702577

4

GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines.

Yu W, Inoue J, Imoto I, Matsuo Y, Karpas A, Inazawa J. Yu W, et al. Among authors: inoue j. J Hum Genet. 2003;48(6):331-335. doi: 10.1007/s10038-003-0026-2. Epub 2003 Apr 29. J Hum Genet. 2003. PMID: 12721791

5

Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets.

Hirasawa A, Saito-Ohara F, Inoue J, Aoki D, Susumu N, Yokoyama T, Nozawa S, Inazawa J, Imoto I. Hirasawa A, et al. Among authors: inoue j. Clin Cancer Res. 2003 Jun;9(6):1995-2004. Clin Cancer Res. 2003. PMID: 12796361

6

Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancer.

Hirasawa A, Aoki D, Inoue J, Imoto I, Susumu N, Sugano K, Nozawa S, Inazawa J. Hirasawa A, et al. Among authors: inoue j. Clin Cancer Res. 2003 Nov 15;9(15):5675-82. Clin Cancer Res. 2003. PMID: 14654551

7

Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Inoue J, Otsuki T, Hirasawa A, Imoto I, Matsuo Y, Shimizu S, Taniwaki M, Inazawa J. Inoue J, et al. Am J Pathol. 2004 Jul;165(1):71-81. doi: 10.1016/S0002-9440(10)63276-2. Am J Pathol. 2004. PMID: 15215163 Free PMC article.

8

Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes.

Inazawa J, Inoue J, Imoto I. Inazawa J, et al. Among authors: inoue j. Cancer Sci. 2004 Jul;95(7):559-63. doi: 10.1111/j.1349-7006.2004.tb02486.x. Cancer Sci. 2004. PMID: 15245590 Free PMC article. Review.

9

Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.

Tanami H, Imoto I, Hirasawa A, Yuki Y, Sonoda I, Inoue J, Yasui K, Misawa-Furihata A, Kawakami Y, Inazawa J. Tanami H, et al. Among authors: inoue j. Oncogene. 2004 Nov 18;23(54):8796-804. doi: 10.1038/sj.onc.1208152. Oncogene. 2004. PMID: 15467732

10

Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers.

Izumi H, Inoue J, Yokoi S, Hosoda H, Shibata T, Sunamori M, Hirohashi S, Inazawa J, Imoto I. Izumi H, et al. Among authors: inoue j. Hum Mol Genet. 2005 Apr 15;14(8):997-1007. doi: 10.1093/hmg/ddi092. Epub 2005 Mar 3. Hum Mol Genet. 2005. PMID: 15746151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,115 results

Search Page

Filters